Skip to main content
main-content

Type 1 diabetes, devices and technology

News

09-25-2019 | Hypoglycemia | EASD 2019 | News

Daytime hyperglycemia, nocturnal hypoglycemia remain problems for EDIC cohort

People with type 1 diabetes rarely achieve the current targets for blood glucose control, with nocturnal hypoglycemia remaining a particular concern, shows an analysis of the DCCT/EDIC cohort.

09-19-2019 | Continuous glucose monitoring | EASD 2019 | News

Majority of MDI users improve glycemic outcomes with CGM

Analysis of the GOLD study suggests that at least three-quarters of people with type 1 diabetes using multiple daily injections benefit from continuous glucose monitoring.

09-17-2019 | Continuous glucose monitoring | EASD 2019 | News

CGM benefits persist with long-term use

The COMISAIR-2 researchers have reported that use of continuous glucose monitoring by people with type 1 diabetes remains high over 3 years, resulting in continued glycemic benefits.

08-27-2019 | Insulin pumps | News

Predictive low-glucose insulin suspend system cuts hypoglycemia in real world

Switching to a predictive low-glucose suspend insulin delivery system significantly reduces hypoglycemia risk in people with diabetes in clinical practice, research shows.

08-08-2019 | Continuous glucose monitoring | News

Pros and cons of CGM described by parents of children with diabetes

Continuous glucose monitoring offers many benefits to the families of young children with type 1 diabetes but also a number of challenges that cannot always be overcome, show results of a qualitative analysis conducted in the USA.

07-23-2019 | Artificial pancreas systems | News

Medtronic closed-loop system with bolus correction promising in first clinical trial

The latest iteration to the Medtronic artificial pancreas system, which includes automated correction boluses, shows promising results in its first home-based trial.

07-12-2019 | Continuous glucose monitoring | Highlight | News

CGM measures have variable correlation with HbA1c

Glycated hemoglobin levels correlate strongly with continuous glucose monitoring-measured average blood glucose and hyperglycemia, but poorly with hypoglycemia, say researchers.

07-05-2019 | Continuous glucose monitoring | News

ATTD consensus group releases time in range recommendations

A statement from an ATTD consensus group has streamlined previously agreed continuous glucose monitoring metrics and set out time in range targets.

06-11-2019 | Hypoglycemia | ADA 2019 | News

CGM data can predict future severe hypoglycemia

Most hypoglycemia outcomes measured by real-time continuous glucose monitoring can be used to predict future severe hypoglycemia in people with type 1 diabetes, with similar levels of accuracy, study findings indicate.

05-31-2019 | Children | News

High variability in insulin needs complicates diabetes management in young children

Children with type 1 diabetes who are aged 6 years or younger have significantly more variability in their insulin needs than adolescents or adults, shows an analysis of closed-loop data.

05-29-2019 | Insulin pumps | News

Real-world data confirm benefits of ‘pump-suspend’ technology in diabetes

Exposure to hypoglycemia deceases significantly with increasing levels of insulin suspension automation in people with type 1 diabetes, real‐world study data show.

05-23-2019 | Type 1 diabetes | News

Treatment simplification a major unmet need in type 1 diabetes

People with type 1 diabetes have high-priority concerns that go beyond glucose control, including complex and mentally taxing treatment and weight gain, report researchers.

05-20-2019 | Continuous glucose monitoring | News

CGM still lags behind SMBG during aerobic exercise

Even with newer devices, continuous glucose monitoring underestimates the fall in glucose levels during exercise, with the drop lagging significantly behind that measured by self-monitoring of blood glucose, research shows.

05-01-2019 | Hypoglycemia | News

Hypoglycemia-prone adults benefit from suspend-before-low pump technology

People with type 1 diabetes at high hypoglycemia risk using insulin pumps have fewer hypoglycemic events if the pump is linked to a continuous glucose monitor and has a suspend-before-low feature, SMILE study data show.

04-08-2019 | Flash glucose monitoring | News

Real-world benefits of flash glucose monitoring confirmed in high-risk cases

Flash glucose monitoring significantly reduces time in hyperglycemia or hypoglycemia in people with diabetes at high risk for either outcome, with the benefit sustained for at least 6 months, real-world study data show.

04-04-2019 | Insulin pumps | Highlight | News

Randomized trial questions superiority of insulin pumps over injections in children

Insulin pumps and multiple daily injections deliver similar glycemic control and safety profiles when allocated alongside education and support at the point of type 1 diabetes diagnosis, say researchers.

04-03-2019 | Continuous glucose monitoring | News

Real-world data support predictive low-glucose alerts for hypoglycemia avoidance

The frequency at which people with type 1 diabetes experience hypoglycemia decreases during the first 30 days after they switch to a continuous glucose monitor that incorporates a predictive low-glucose alert, research shows.

03-25-2019 | Artificial pancreas systems | News

Real-world data highlight closed-loop frustrations for youth users

System problems and irritations lead to nearly two in five children abandoning use of closed-loop insulin delivery in a real-world setting, researchers have reported.

03-25-2019 | Hypoglycemia | News

Problem of hypoglycemia unawareness highlighted in older people with type 1 diabetes

Baseline data from the WISDM trial show that older adults with type 1 diabetes who have impaired awareness of hypoglycemia symptoms can spend over half an hour per day with extremely low blood glucose levels.

03-13-2019 | Canagliflozin | DUKPC 2019 | News

ABCD audit data reveal improved glycemic control with use of FreeStyle Libre, canagliflozin

Analyses of real-world audit data show positive initial results for the flash glucose monitoring system FreeStyle Libre and the sodium-glucose cotransporter 2 inhibitor canagliflozin.

Image Credits